Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.41b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Annual Financial Report

7 Apr 2022 10:28

RNS Number : 6513H
Jardine Matheson Hldgs Ltd
07 April 2022
Β 

JARDINE MATHESON HOLDINGS LIMITED

Β 

PUBLICATION OF 2021 ANNUAL REPORT AND NOTICE OF ANNUAL GENERAL MEETING

Β 

Jardine Matheson Holdings Limited (the 'Company') has today published on the Company's website, www.jardines.com, its Annual Report in respect of the year ended 31st December 2021 (the 'Annual Report'). The notice of the 2022 Annual General Meeting and form of proxy are also available on the website.

Β 

A printed copy of the Annual Report, together with the notice of the 2022 Annual General Meeting and form of proxy (together the 'Documents'), are today being posted to shareholders. At the time of sending the Documents, it is impossible to predict what impact COVID-19 might have on postal services around the globe. Accordingly, there may be delays for the Documents to be received by some registered shareholders. In light of these possible delays, registered shareholders should consider visiting the Company's website to access and print the proxy form to ensure that they can complete and send it to the Company's registrars/transfer agents by the deadline set out in the proxy form. If investors require assistance, please contact the Company's registrars/transfer agents. It is also recommended that investors appoint the Chairman of the Meeting as their proxy.

Β 

Copies of the Documents have also been submitted to the Financial Conduct Authority (the 'FCA') in the United Kingdom via the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Β 

The information required by the Disclosure Guidance and Transparency Rule 6.3.5 of the FCA is included in the preliminary announcement of results for the year ended 31st December 2021 made by the Company on 3rd March 2022 and in the Annual Report.

Β 

Cancellation of cross-shareholding

Β 

Further to the announcement made by the Company on 8th March 2021 in relation to its intention to cancel the 59% per cent. shareholding in the Company held (directly and indirectly) by Jardine Strategic Limited ('Jardine Strategic' and the 'Share Cancellation', respectively), the Company is proposing to seek the approval of shareholders at the 2022 Annual General Meeting of Resolutions relating to a reduction of capital in the Company (the 'Capital Reduction') as well as a proposed amendment the Company's bye-laws in order to implement the Share Cancellation.

Β 

If the Capital Reduction and amendments to the Company's bye-laws are approved by shareholders, the 59% shareholding held (directly and indirectly) by Jardine Strategic would be cancelled, and no consideration would be paid. The notice of the 2022 Annual General Meeting contains further details of these matters.

Β 

The Board considers the Capital Reduction and the associated Resolutions to be in the best interests of the Company and its shareholders as a whole and unanimously recommends that shareholders vote in favour of such Resolutions.

Β 

Β 

Jonathan Lloyd, Jardine Matheson LimitedFor and on behalf of Jardine Matheson Holdings Limited

Β 

7th April 2022

Β 

www.jardines.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACSSSISUWEESEEL
Date   Source Headline
26th Jun 202610:21 amRNSDirector/PDMR Shareholding
25th Jun 202611:34 amRNSTransaction in Own Shares
25th Jun 202610:59 amRNSProposed Share Buyback
25th Jun 20267:00 amRNSTransaction in Own Shares
24th Jun 202612:15 pmRNSDirector/PDMR Shareholding
24th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 202611:59 amRNSTransaction in Own Shares
22nd Jun 202611:10 amRNSDirector/PDMR Shareholding
22nd Jun 20267:00 amRNSTransaction in Own Shares
18th Jun 202611:05 amRNSTransaction in Own Shares
18th Jun 202610:26 amRNSDirector/PDMR Shareholding
17th Jun 202610:58 amRNSTransaction in Own Shares
17th Jun 202610:54 amRNSDirector/PDMR Shareholding
16th Jun 20267:00 amRNSJardines updates strategy at investor day
29th May 202610:53 amRNSTotal Voting Rights
29th May 202610:47 amRNSDirector/PDMR Shareholding
28th May 202611:31 amRNSTransaction in Own Shares
27th May 202610:27 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSAcquisition of I-MED Radiology Network
22nd May 202610:23 amRNSInterim Management Statement
19th May 202612:22 pmRNSINTERIM MANAGEMENT STATEMENT
18th May 202612:57 pmRNSNotification of Issuance of Equity Securities
18th May 202612:30 pmRNSDirector/PDMR Shareholding
7th May 20261:01 pmRNSAdditional Listing
7th May 202612:49 pmRNSDirector/PDMR Shareholding
7th May 202612:44 pmRNSResult of AGM
5th May 202610:54 amRNSTransaction in Own Shares
5th May 202610:19 amRNSTransaction in Own Shares
30th Apr 202611:51 amRNSTotal Voting Rights
30th Apr 202611:50 amRNSTransaction in Own Shares
30th Apr 202610:47 amRNSJC&C Interim Management Statement
29th Apr 202612:28 pmRNSPT Astra 2026 First Quarter Financial Statements
29th Apr 202611:59 amRNSTransaction in Own Shares
29th Apr 202610:48 amRNSDividend
28th Apr 202611:35 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202611:26 amRNSDividend
22nd Apr 202611:12 amRNSTransaction in Own Shares
21st Apr 202610:57 amRNSTransaction in Own Shares
20th Apr 202611:01 amRNSTransaction in Own Shares
14th Apr 202611:31 amRNSTransaction in Own Shares
13th Apr 202611:27 amRNSTransaction in Own Shares
10th Apr 202611:23 amRNSTransaction in Own Shares
8th Apr 202611:53 amRNSTransaction in Own Shares
8th Apr 202610:25 amRNSAnnual Financial Report
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20268:02 amRNSTransaction in Own Shares
1st Apr 202611:17 amRNSTransaction in Own Shares
1st Apr 202610:34 amRNSCirc re. Scrip Dividend Scheme
1st Apr 202610:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.